Subtle variations in Pten dose determine cancer susceptibility (original) (raw)
Accession codes
Accessions
Gene Expression Omnibus
NCBI Reference Sequence
References
- Friend, S.H. Alfred Knudson: the importance of a visionary who enables scientists. Genes Chromosom. Cancer 38, 326–328 (2003).
Article Google Scholar - Trotman, L.C. et al. Pten dose dictates cancer progression in the prostate. PLoS Biol. 1, E59 (2003).
Article Google Scholar - Yan, H. et al. Small changes in expression affect predisposition to tumorigenesis. Nat. Genet. 30, 25–26 (2002).
Article CAS Google Scholar - Salmena, L., Carracedo, A. & Pandolfi, P.P. Tenets of PTEN tumor suppression. Cell 133, 403–414 (2008).
Article CAS Google Scholar - Knudson, A.G. Two genetic hits (more or less) to cancer. Nat. Rev. Cancer 1, 157–162 (2001).
Article CAS Google Scholar - Knudson, A.G. Hereditary cancer: two hits revisited. J. Cancer Res. Clin. Oncol. 122, 135–140 (1996).
Article CAS Google Scholar - Ma, L. et al. Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev. 19, 1779–1786 (2005).
Article CAS Google Scholar - Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P.P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348–355 (1998).
Article CAS Google Scholar - Venkatachalam, S. et al. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J. 17, 4657–4667 (1998).
Article CAS Google Scholar - Di Cristofano, A. & Pandolfi, P.P. The multiple roles of PTEN in tumor suppression. Cell 100, 387–390 (2000).
Article CAS Google Scholar - Suzuki, A. et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8, 1169–1178 (1998).
Article CAS Google Scholar - Podsypanina, K. et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA 96, 1563–1568 (1999).
Article CAS Google Scholar - Morita, M. et al. HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J. 22, 1134–1146 (2003).
Article CAS Google Scholar - McDevitt, M.A., Shivdasani, R.A., Fujiwara, Y., Yang, H. & Orkin, S.H.A. “Knockdown” mutation created by _cis_-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc. Natl. Acad. Sci. USA 94, 6781–6785 (1997).
Article CAS Google Scholar - Di Cristofano, A. et al. Impaired Fas response and autoimmunity in Pten+/− mice. Science 285, 2122–2125 (1999).
Article CAS Google Scholar - Hong, F. et al. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22, 2825–2827 (2006).
Article CAS Google Scholar - Saal, L.H. et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res. 65, 2554–2559 (2005).
Article CAS Google Scholar - Bose, S. et al. Reduced expression of PTEN correlates with breast cancer progression. Hum. Pathol. 33, 405–409 (2002).
Article CAS Google Scholar - Richardson, A.L. et al. X-chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9, 121–132 (2006).
Article CAS Google Scholar - Carver, B.S. et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat. Genet. 41, 619–624 (2009).
Article CAS Google Scholar - Trotman, L.C. et al. Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441, 523–527 (2006).
Article CAS Google Scholar
Acknowledgements
We thank Z. Chen for help with genotyping and characterization of the Pten hypomorphic mutant mice. This study was supported, in part, by US National Cancer Institute grants (SPORE 92629 in Prostate Cancer, MMHCC CA-84292 and RO1 CA-82328). A.C. was supported by a long-term European Molecular Biology Organization fellowship.
Author information
Author notes
- Lloyd C Trotman
Present address: Current address: Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA., - Arkaitz Carracedo and John G Clohessy: These authors contributed equally to this work.
Authors and Affiliations
- Department of Medicine, Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Andrea Alimonti, Arkaitz Carracedo, John G Clohessy, Caterina Nardella, Ainara Egia, Leonardo Salmena, Katia Sampieri, William J Haveman & Pier Paolo Pandolfi - Department of Pathology, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Andrea Alimonti, Arkaitz Carracedo, John G Clohessy, Caterina Nardella, Ainara Egia, Leonardo Salmena, Katia Sampieri, William J Haveman & Pier Paolo Pandolfi - Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Andrea Alimonti, Arkaitz Carracedo, John G Clohessy, Lloyd C Trotman, Caterina Nardella, Ainara Egia, Leonardo Salmena, William J Haveman & Pier Paolo Pandolfi - Department of Pathology, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Andrea Alimonti, Arkaitz Carracedo, John G Clohessy, Caterina Nardella, Ainara Egia, Leonardo Salmena, William J Haveman, Edi Brogi & Pier Paolo Pandolfi - Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA
Andrea L Richardson - Faculty of Arts and Sciences (FAS), Center for Systems Biology, Harvard University, Cambridge, Massachusetts, USA
Jiangwen Zhang
Authors
- Andrea Alimonti
You can also search for this author inPubMed Google Scholar - Arkaitz Carracedo
You can also search for this author inPubMed Google Scholar - John G Clohessy
You can also search for this author inPubMed Google Scholar - Lloyd C Trotman
You can also search for this author inPubMed Google Scholar - Caterina Nardella
You can also search for this author inPubMed Google Scholar - Ainara Egia
You can also search for this author inPubMed Google Scholar - Leonardo Salmena
You can also search for this author inPubMed Google Scholar - Katia Sampieri
You can also search for this author inPubMed Google Scholar - William J Haveman
You can also search for this author inPubMed Google Scholar - Edi Brogi
You can also search for this author inPubMed Google Scholar - Andrea L Richardson
You can also search for this author inPubMed Google Scholar - Jiangwen Zhang
You can also search for this author inPubMed Google Scholar - Pier Paolo Pandolfi
You can also search for this author inPubMed Google Scholar
Contributions
A.A., L.C.T. and P.P.P. conceived and designed the experiments. A.A., A.C., J.G.C., C.N., A.E., L.S., K.S. and W.J.H. performed the experiments. A.A., A.C., J.G.C., C.N., L.S., E.B., A.L.R., J.Z. and P.P.P. analyzed the data. A.A., A.C., J.G.C. and P.P.P. wrote the paper.
Corresponding author
Correspondence toPier Paolo Pandolfi.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Alimonti, A., Carracedo, A., Clohessy, J. et al. Subtle variations in Pten dose determine cancer susceptibility.Nat Genet 42, 454–458 (2010). https://doi.org/10.1038/ng.556
- Received: 15 December 2009
- Accepted: 23 February 2010
- Published: 18 April 2010
- Issue Date: May 2010
- DOI: https://doi.org/10.1038/ng.556